PALI - Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher | Benzinga
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday.
The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P 500, also fell, dropping, 0.80% to 4,460.96.
Check This Out: Top 5 Health Care Stocks That May Explode In Q3
Leading and Lagging Sectors
Utilities shares jumped by 0.2% on Wednesday.
In trading on Wednesday, information technology shares fell by 1.5%.
Top Headline
Core & Main Inc (NYSE: CNM) reported a second-quarter miss and narrowed its FY23 guidance.
Core & Main reported second-quarter FY23 sales of $1.861 billion flat year-over-year, missing the consensus of $1.88 billion. EPS decreased 4.3% Y/Y to $0.66, missing the consensus of $0.68.
Equities Trading UP
Palisade Bio, Inc. (NASDAQ: PALI) shares shot up 132% to $1.60. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.
Shares of Cidara Therapeutics, Inc. (NASDAQ: CDTX) got a boost, shooting 20% to $0.9551 after Janssen elected to proceed under its license agreement relating to influenza candidate.
Marin Software Incorporated (NASDAQ: MRIN) shares were also up, gaining 52% to $0.6509 after the company reported HubSpot integration.
Equities Trading DOWN
EZGO Technologies Ltd. (NASDAQ: EZGO) shares dropped 83% to $0.2987 after the company ...